# Progress Note 07 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sonny Liston (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX007-SYN-TD
- Date: 1969-10-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Malcolm Achebe-Whitford, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Four-month review of blood pressure and drinking. **S**

## History of present illness

Sonny Liston returns for his four-month review. The commission physician cleared him to box after reviewing his readings, and he is back to full sparring. His home readings average 120/76 mmHg. He takes amlodipine 10 mg and valsartan 160 mg and naltrexone 50 mg each morning. He drinks about eight drinks a week, never more than three in a day, and none in the two weeks before a bout. He is sleeping well and says he feels sharper in training. He has thought about the adult reading class he was told about and wants to wait until after his next fight. No thoughts of suicide. **S**

| Element | Detail |
|---|---|
| Home readings | Average 120/76 mmHg |
| AUDIT | 7, from 16 at intake |
| GGT | 41 U/L, normal |
| PHQ-9 | 2; item 9 scored 0 |
| Vaccine today | Influenza |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations or swelling at rest |
| Neurological | Negative | No dizziness or headaches |
| Gastrointestinal | Negative | No nausea |
| Psychiatric | Negative | Mood good; no thoughts of suicide |

4 systems reviewed. **S**

## Current medications

- Amlodipine 10 mg and valsartan 160 mg combined oral tablet, one tablet each morning **S**
- Naltrexone 50 mg oral tablet, one tablet each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/76 mmHg; pulse 56 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 99% on room air; weight 97 kg; BMI 28.3 kg/m². All vital signs are synthetic.

AUDIT: 7; GGT: 41 U/L; PHQ-9: 2. All results are synthetic.

## Change since baseline

- AUDIT: 16 at baseline, 7 at this visit **S**
- GGT: 88 U/L (high) at baseline, 41 U/L at this visit **S**
- PHQ-9: 6 at baseline, 2 at this visit **S**

## Immunizations given today

- Influenza vaccine, 1969-1970 season **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 122/76 mmHg (average of two); pulse 56; weight 97.0 kg |
| Cardiovascular | Regular rhythm; no edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hypertension, stage 2** (I10). Controlled in the clinic and at home. **S**
   - Continue amlodipine 10 mg and valsartan 160 mg.
   - Potassium and creatinine in about two months (six months on valsartan).
   - Lipids, glucose and urine albumin at the next preventive visit; echocardiogram in about eight months to look for regression of the hypertrophy.
2. **Alcohol use disorder, moderate** (F10.20). Drinking within his own goal and in the low-risk range (AUDIT 7), with GGT normal; too soon to call remission, which needs at least three months without the criteria. **S**
   - Continue naltrexone for at least a few more months, then decide together whether to stop.
   - Plan for the period after a fight, when he says the pull to drink is strongest.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure (seated, large cuff, average of two readings), weight and BMI, heart sounds | Every visit | Completed today | 122/76 mmHg; weight 97.0 kg |
| Examination | Out-of-office blood pressure (ambulatory or home monitoring) | At diagnosis and after each treatment change | Completed today | Home average 120/76 mmHg |
| Laboratory | Potassium, creatinine and eGFR | Baseline; two to four weeks after starting an ARB; then every six months on an ARB | Due | Next in about two months, six months after starting valsartan |
| Laboratory | Lipids, glucose or A1c, urine albumin-to-creatinine ratio, TSH | At diagnosis, then yearly (TSH at diagnosis) | Up to date | Done at intake; next at the preventive visit next year |
| Imaging | Echocardiogram | At diagnosis for stage 2 hypertension or suspected LVH; repeat as indicated | Up to date | Repeat in about eight months |
| Medication safety | Antihypertensive tolerance (ankle edema, dizziness) and adherence by teach-back | Each follow-up and each dose change | Completed today | No edema today; no dizziness; teach-back correct |
| Referral | Fitness to compete (AHA/ACC athlete statement) | At diagnosis and before returning to competition | Completed today | Cleared by the commission physician; blood pressure checked before each bout |
| Survey | Drinking (AUDIT-C, drinks per week, drinking days) | Every follow-up during treatment; full AUDIT at about four months | Completed today | Full AUDIT 7, from 16; about 8 drinks a week |
| Laboratory | Liver tests (AST, ALT, GGT) | Baseline; about two months after starting naltrexone or cutting down; then as indicated | Completed today | GGT 41 U/L, now normal |
| Medication safety | Naltrexone: nausea, liver tests, and opioid-blockade wallet card | Each follow-up after starting | Completed today | Well tolerated; wallet card carried |
| Survey | PHQ-9 | Yearly with hypertension; sooner with symptoms | Completed today | PHQ-9 2, item 9 scored 0 |
| Survey | Suicide-risk review (structured questions) and safety plan | Every visit | Completed today | No thoughts of suicide; safety plan kept |
| Self-management | Health literacy: teach-back, picture card, read-aloud consent, voice reminders | Every visit | Completed today | Teach-back correct; the adult reading class offered again, and he will decide after his next fight |

## Goal progress

- Confirm or rule out hypertension with out-of-office readings before any medicine. Outcome by 1969-06-23: Ambulatory monitoring confirmed stage 2 hypertension (daytime 146/94 mmHg). **S**
- Blood pressure under 130/80 mmHg in the clinic and at home by four months. Outcome by 1969-10-20: Clinic 122/76 mmHg; home average 120/76 mmHg on amlodipine 10 mg and valsartan 160 mg. **S**
- Drink within the goal he set: no more than 14 drinks a week and no more than 4 on any day, and none in the two weeks before a fight. Outcome by 1969-10-20: About 8 drinks a week with no day above 3; AUDIT 7; GGT normal. **S**
- Explain his medicines and blood pressure plan back in his own words. Outcome by 1969-07-21: Teach-back correct at four weeks with the picture card. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- CMID: Clinical Monitoring Intelligence Database, hypertension and depression monographs (2026), Aether Forge
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (Black HR, et al.) (2015), American Heart Association and American College of Cardiology (Circulation 2015)
- The Healthcare Professional's Core Resource on Alcohol (2026), National Institute on Alcohol Abuse and Alcoholism
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018), American Psychiatric Association (Am J Psychiatry 2018;175(1):86-90)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- AHRQ Health Literacy Universal Precautions Toolkit, 3rd Edition (2024), Agency for Healthcare Research and Quality
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Potassium and creatinine in about two months. Review in three months, sooner after any bout with a head injury. Preventive visit in ten months. Call 988 or the clinic at any time if thoughts of suicide arise. **S**

